OBJECTIVE: The human papillomavirus (HPV) can cause premalignant and malignant tumors in the anogenital and oropharyngeal regions. The aim of this study was to describe the association in the prevalence of cervical, anal, and oral HPV infections in high-risk patients with biopsy-confirmed high-grade cervical lesion compared to low-risk women. STUDY DESIGN: A total of 718 immunocompetent women were enrolled in the study. The high-risk (HR) group consisted of 473 patients with biopsy-confirmed high-grade cervical lesion while the low-risk (LR) group consisted of other 245 women. All participants completed an anonymous self-administered questionnaire and were subjected to cervical, anal, and oral HPV genotyping using the Linear array HPV test. RESULTS: A total of 81.4% women were infected in the cervix, 43.3% in the anus, and 2.7% in the oral cavity in the HR group in comparison with only 26.9%, 24.5%, and 1.4% in the low-risk LR group, respectively. The cervical and anal HPV infections were much more frequent in the HR patients (p < 0.001); the difference in the oral HPV prevalence was not significant (p = 0.511) between groups. Concurrent cervical-anal infection was observed in 39.3% of HR women and in 8.3% of the LR patients (p < 0.001) and it significantly increased with the grade of cervical lesion (ptrend<0.001). The higher prevalence of concurrent cervical-oral, anal-oral, and cervical-anal-oral infections in HR women was statistically not significant according to the generally small oral HPV prevalence. CONCLUSIONS: All HPV infections occurred more often in HR than in LR women but not all results were statistically significant. The genotype HPV 16 was found in approximately half of all infections at all sites.

1st Faculty of Medicine Charles University and General University Hospital Gynaecologic Oncology Centre Apolinarska 18 Praha 2 128 51 Prague Czech Republic

1st Faculty of Medicine Charles University and Hospital Na Bulovce Department of Gynaecology and Obstetrics Budinova 2 Praha 8 180 81 Prague Czech Republic

Institute of Biostatistics and Analyses Masaryk University Kamenice 3 625 00 Brno Czech Republic

Zobrazit více v PubMed

Forman D., de Martel C., Lacey C.J. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Suppl 5):F12–23. PubMed

Giuliano A.R., Nyitray A.G., Kreimer A.R. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015;136(12):2752–2760. PubMed PMC

Ciccarese G., Herzum A., Rebora A., Drago F. Prevalence of genital, oral, and anal HPV infection among STI patients in Italy. J Med Virol. 2017;89(6):1121–1124. PubMed

Sehnal B., Dusek L., Cibula D. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia. J Clin Virol. 2014;59:18–23. PubMed

Slama J., Sehnal B., Dusek L., Zima T., Cibula D. Impact of risk factors on prevalence of anal HPV infection in women with simultaneous cervical lesion. Neoplasma. 2015;62(2):308–314. PubMed

Hernandez B.Y., McDuffie K., Zhu X. Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev. 2005;14(11):2550–2556. PubMed PMC

Shvetsov Y.B., Hernandez B.Y., McDuffie K. Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study. Clin Infect Dis. 2009;48(5):536–546. PubMed PMC

Fu T.C., Hughes J.P., Feng Q., Hulbert A. Epidemiology of human papillomavirus detected in the oral cavity and fingernails of mid-adult women. Sex Transm Dis. 2015;42(12):677–685. PubMed PMC

Kedarisetty S., Orosco R.K., Hecht A.S., Chang D.C., Weissbrod P.A., Coffey C.S. Concordant oral and vaginal human papillomavirus infection in the United States. JAMA Otolaryngol Head Neck Surg. 2016;142(5):457–465. PubMed

Steinau M., Hariri S., Gillison M.L. Prevalence of cervical and oral human papillomavirus infections among US women. J Infect Dis. 2014;209(11):1739–1743. PubMed PMC

Crawford R., Grignon A.L., Kitson S. High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology. BMC Cancer. 2011;11:473. PubMed PMC

Cañadas M.P., Bosch F.X., Junquera M.L. Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J Clin Microbiol. 2004;42(3):1330–1332. PubMed PMC

Kreimer A.R., Bhatia R.K., Messeguer A.L., González P., Herrero R., Giuliano A.R. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis. 2010;37(6):386–391. PubMed

Shigeishi H., Sugiyama M. Risk factors for oral human papillomavirus infection in healthy individuals: a systematic review and meta-analysis. J Clin Med Res. 2016;8(10):721–729. PubMed PMC

Wood Z.C., Bain C.J., Smith D.D., Whitemann D.C., Antonsson A. Oral human papillomavirus infection incidence and clearance: a systematic review of the literature. J Gen Virol. 2017;98(4):519–526. PubMed

Gillison M.L., Broutian T., Pickard R.K. Prevalence of oral HPV infection in the United States. JAMA. 2012;307:693–703. 2009-2010. PubMed PMC

Fakhry C., D’Souza G., Sugar E. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. J Clin Microbiol. 2006;44(12):4479–4485. PubMed PMC